Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 27, 2022, titled "Glenmark Pharmaceuticals receives ANDA approval for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg".